Pediatric Neurology
Volume 41, Issue 6 , Pages 419-427 , December 2009

CD40 Ligand Deficiency: Neurologic Sequelae With Radiographic Correlation

  • Shrinivas Bishu, MD

      Affiliations

    • Section on Neuroadaptation and Protein Metabolism, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
    • Corresponding Author InformationCommunications should be addressed to: Dr. Bishu; Section on Neuroadaptation and Protein Metabolism; NIMH-NIH; 9000 Rockville Pike; Building 10, Room 2D54; Bethesda, MD 20892-1298.
    • ,
  • Deepak Madhavan, MD

      Affiliations

    • Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska
    • ,
  • Phillip Perez, MD

      Affiliations

    • Department of Psychiatry, Georgetown University, Washington, DC
    • ,
  • Lucy Civitello, MD

      Affiliations

    • Department of Neurology, Children's National Medical Center, Washington, DC
    • ,
  • Shuying Liu, RN

      Affiliations

    • Laboratory of Host Defenses, National Institute of Allergy and Infectious Disease, Bethesda, Maryland
    • ,
  • Margaret Fessler, RN

      Affiliations

    • Laboratory of Host Defenses, National Institute of Allergy and Infectious Disease, Bethesda, Maryland
    • ,
  • Steven M. Holland, MD

      Affiliations

    • Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, Bethesda, Maryland
    • ,
  • Ashish Jain, MD

      Affiliations

    • Laboratory of Host Defenses, National Institute of Allergy and Infectious Disease, Bethesda, Maryland
    • ,
  • Maryland Pao, MD

      Affiliations

    • Psychiatry Consultation Liaison Service, Office of the Clinical Director, National Institute of Mental Health, Bethesda, Maryland

Received 19 March 2009 ,Accepted 6 July 2009.

References 

  1. Seyama K, Nonoyama S, Gangsaas I, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–2434
  2. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo AA. 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992;89:6550–6554
  3. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992;22:2573–2578
  4. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54
  5. Cunningham CK, Bonville CA, Ochs HD, et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr. 1999;134:584–588
  6. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–384
  7. Leiva LE, Junprasert J, Hollenbaugh D, Sorensen RU. Central nervous system toxoplasmosis with an increased proportion of circulating γδ T cells in a patient with hyper-IgM syndrome. J Clin Immunol. 1998;18:283–290
  8. Blaeser F, Kelly M, Siegrist K, et al. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol (Orlando, Fla). 2005;117:231–237
  9. Hecht JH, Glenn OA, Wara DW, Wu YW. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol. 2007;36:186–189
  10. Aschermann Z, Gomori E, Kovacs GG, et al. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol. 2007;64:273–276
  11. Suzuki H, Takahashi Y, Miyajima H. Progressive multifocal leukoencephalopathy complicating X-linked hyper-IgM syndrome in an adult. Intern Med. 2006;45:1187–1188
  12. Rotbart HA, Webster AD. Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32:228–235
  13. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. 2008;28:413–437x
  14. McKinney RE, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987;9:334–356
  15. Rudge P, Webster AD, Revesz T, et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain. 1996;119:1–15
  16. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. [Erratum in: J Allergy Clin Immunol 2006;117:1483. Dosage error in article text.] J Allergy Clin Immunol. 2006;117(4 Suppl):S525–S553
  17. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85:193–202
  18. Wilfert CM, Buckley RH, Mohanakumar T, et al. Persistent and fatal central-nervous-system Echovirus infections in patients with agammaglobulinemia. N Engl J Med. 1977;296:1485–1489
  19. Misbah SA, Spickett GP, Ryba PC, et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol. 1992;12:266–270
  20. Halliday E, Winkelstein J, Webster AD. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect. 2003;46:1–8
  21. Erlendsson K, Swartz T, Dwyer JM. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin. N Engl J Med. 1985;312:351–353
  22. Dwyer JM, Erlendsson K. Intraventricular gamma-globulin for the management of enterovirus encephalitis. Pediatr Infect Dis J. 1988;7(5 Suppl):S30–S33
  23. Weiner LS, Howell JT, Langford MP, et al. Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis. 1979;140:858–863
  24. Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17:903–925
  25. Ziegner UH, Kobayashi RH, Cunningham-Rundles C, et al. Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol. 2002;102:19–24
  26. Subauste CS, Wessendarp M, Sorensen RU, Leiva LE. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol. 1999;162:6690–6700
  27. Whitmire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. [Erratum in: J Virol 1997;71:1736] J Virol. 1996;70:8375–8381
  28. Borrow P, Tough DF, Eto D, et al. CD40 ligand-mediated interactions are involved in the generation of memory CD8+ cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol. 1998;72:7440–7449
  29. Andreasen SO, Christensen JE, Marker O, Thomsen AR. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol. 2000;164:3689–3697
  30. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393:480–483
  31. Lu Z, Yuan L, Zhou X, Sotomayor E, Levitsky HI, Pardoll DM. CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes. J Exp Med. 2000;191:541–550
  32. Ameratunga R, Lederman HM, Sullivan KE, et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr. 1997;131:147–150
  33. de Saint Basile G, Geissmann F, Flori E, et al. Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3. J Clin Invest. 2004;114:1512–1517
  34. Monafo WJ, Polmar SH, Neudorf S, Mather A, Filipovich AH. A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation. Clin Exp Immunol. 1992;90:390–393
  35. de la Salle H, Hanau D, Fricker D, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency [Erratum in: Science 1994;266:1464]. Science. 1994;265:237–241
  36. Notarangelo L, Casanova JL, Conley ME, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006;117:883–896
  37. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr. 1993;123:921–928
  38. van Benten I, Koopman L, Niesters B, et al. Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol. 2003;14:363–370
  39. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719–724
  40. Wang D, Coscoy L, Zylberberg M, et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A. 2002;99:15687–15692
  41. Wang D, Urisman A, Liu YT, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol. 2003;1(2):e2

PII: S0887-8994(09)00349-X

doi: 10.1016/j.pediatrneurol.2009.07.003

Pediatric Neurology
Volume 41, Issue 6 , Pages 419-427 , December 2009

Article Tools

* Image Usage & Resolution